US Pharma MarketingThe competing modalities are each gaining traction in lung cancer. But will they ultimately become allies?
Competition is brewing between ADCs and bispecifics
Competition is brewing between ADCs and bispecifics is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: PharmaVoice